Devoe, L D <br/><br/>
Metastatic pheochromocytoma in pregnancy and fetal biophysical assessment after maternal administration of alpha-adrenergic, beta-adrenergic, and dopamine antagonists.  [electronic resource] 

 -  Obstetrics and gynecology  Sep 1986 
 - 15S-18S p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>0029-7844 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Catecholamines--blood<br/>Drug Therapy, Combination<br/>Female<br/>Fetal Heart--drug effects<br/>Fetal Monitoring<br/>Fetus--drug effects<br/>Heart Rate--drug effects<br/>Humans<br/>Methyltyrosines--therapeutic use<br/>Pheochromocytoma--drug therapy<br/>Prazosin--therapeutic use<br/>Pregnancy<br/>Pregnancy Complications, Neoplastic--drug therapy<br/>Sympatholytics--adverse effects<br/>Timolol--therapeutic use<br/>Tyrosine 3-Monooxygenase--antagonists & inhibitors<br/>alpha-Methyltyrosine